| Pharmaceutical active ingredients: |
| Nabumetone |
| Available forms, composition and doses of Consolan: |
| N / A |
| Consolan medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX01 - Nabumetone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Conray 35 | Diatrizoate | Unidentified Pharmaceutical Company |
| Consenil | Ethaverine | Unidentified Pharmaceutical Company |
| Conserve | Spinosad | Unidentified Pharmaceutical Company |
| Consist | Trifloxystrobin | Unidentified Pharmaceutical Company |
| Consol Violet | Methyl Violet | Unidentified Pharmaceutical Company |
| Constan | Alprazolam | Unidentified Pharmaceutical Company |
| Constimol | Pemoline | Unidentified Pharmaceutical Company |
| Cont | Metronidazole | Unidentified Pharmaceutical Company |
| Contalyl | Methixene | Unidentified Pharmaceutical Company |
| Conteben | Thioacetazone | Unidentified Pharmaceutical Company |